The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...

Growth is driven by increasing demand for personalized treatment, improved delivery technologies, and biosimilars, despite challenges like high costs and regulatory demands Rapid Acting Insulin Market ...

Q3 2025 Earnings Call Transcript November 6, 2025 Tandem Diabetes Care, Inc. reports earnings inline with expectations.

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full ...